Introduction: Antibody Libraries, Phage Scaffolds, and Therapeutic Discovery Pipelines Antibodies are the cornerstone of modern biologics. From checkpoint inhibitors and bispecifics to antibody-drug conjugates (ADCs), they dominate the therapeutic pipeline across oncology, autoimmune disease, infectious disease, and rare disorders. Yet the success of any antibody program hinges on the ability to discover high-affinity, high-specificity binders—molecules […]
Category: Phage CDMO
The Top 12 Things Every Great Phage CDMO Should Do
As bacteriophages transition from research tools to real-world therapeutics and biocontrol solutions, the role of the phage CDMO (Contract Development and Manufacturing Organization) has become pivotal. Unlike standard biologics such as monoclonal antibodies or recombinant proteins, phages are living biological entities with unique life cycles, host dependencies, and manufacturing constraints. Scaling their production requires expertise […]